IBM (NYSE: IBM) has announced new incident response capabilities, from its IBM Resilient security portfolio, to help companies address the new General Data Protection Regulation (GDPR). These capabilities are designed to help clients rehearse, prepare for and manage the new regulations. GDPR is one of the biggest changes in data privacy law in decades which goes into effect on May 25, 2018.

With their joint research alliance, Siemens Healthineers and the Fraunhofer Institute for Medical Image Computing MEVIS will support physicians in finding the right course of therapy for their patients. Both partners are jointly developing artificial intelligence software systems to facilitate diagnosis and therapy decisions with the help of advanced data integration, comprehensive databases, and automatic recognition of patterns and regularities in data (deep machine learning).

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation.

Opinion Article by: Jane Rendall, UK Managing Director, Sectra; Fredrik Gustavsson, Chief Technology Officer.
Pressure to improve sustainability and reduce isolation in healthcare has renewed the hunger for a different approach to IT. Installing software in individual organisations, and then managing it locally on hospital servers, is a resource hungry method that for many organisations is starting to reach its limits in the race to digital maturity.

AXA is partnering with eHealth Hub and its Solution Match service to source nutrition and smoking cessation solution partners. AXA is today the number one global insurance brand, a worldwide leader in insurance and asset management operating in more than 60 countries, with 165,000 employees and agents serving 107 million clients.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has released the second annual Future Health Index. The study identifies a significant gap between healthcare professionals' and the general population's perceptions, and the reality of the readiness of health systems for the future.

MAP Health Management and IBM (NYSE: IBM) Watson Health have announced a partnership that aims to address the pervasive problem of relapse among Americans suffering from Substance Use Disorder, a chronic disease. MAP will integrate Watson cognitive technologies into the MAP Recovery Network Platform to enhance the platform's existing capabilities around patient risk models.